Previous studies have demonstrated that RIP1 kinase activation also leads to neuroinflammation in multiple central nervous system (CNS) diseases such as Alzheimer′s disease (AD)19 and amyotrophic lateral sclerosis (ALS)20. Here, RIPK1 is linked to Alzheimer disease.